GlassScriptPhysician profile
Moshe Schwartz
NPI 1720091408
$2,455.46
in general payments reported to CMS, 2019-2025
20 companies · $491 in 2025
The $491 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $528 · 2020: $169 · 2021: $116 · 2022: $359 · 2023: $620 · 2024: $173 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,023 · Consulting Fee: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,023.46 |
| Consulting Fee | $260.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $541.72 | 2022-2025 | Acuvue |
| Sight Sciences, INC. | $334.19 | 2019-2020 | |
| Biotissue Holdings INC. | $317.30 | 2022-2024 | |
| Bausch & Lomb Americas INC. | $215.46 | 2022-2025 | Infuse, Vyzulta, Biotrue One Day |
| Tarsus Pharmaceuticals, INC. | $169.49 | 2025 | Xdemvy |
| Shire North American Group INC | $123.43 | 2019 | |
| Sun Pharmaceutical Industries INC. | $118.43 | 2024-2025 | |
| Alcon Vision LLC | $108.39 | 2019-2021 | |
| Maculogix, INC. | $88.80 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $69.63 | 2021 | |
| Harrow Eye, LLC | $68.63 | 2025 | Vevye |
| Dompe US, INC. | $53.31 | 2021-2025 | Oxervate |
| Oyster Point Pharma, INC. | $49.59 | 2022-2024 | Tyrvaya |
| Menicon America INC | $44.42 | 2022-2024 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oasis Medical, INC. | $34.00 | 2025 | Oasis Tears |
| Eyevance Pharmaceuticals LLC | $30.87 | 2021-2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Thea Pharma INC. | $16.63 | 2023 | |
| Glaukos Corporation | $15.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moshe Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.